FDA Updates

Latest News

Illustration of cancer cells in 3D: Image credit: Vusal | stock.adobe.com
The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell Lung Cancer

May 17th 2024

Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.

Follicular lymphoma -- Image credit: Lisa | stock.adobe.com
FDA Grants Accelerated Approval for Liso-Cel in Patients With Relapsed or Refractory Follicular Lymphoma

May 16th 2024

a close-up of a lung with cancer cells and an overlay of a magnified section of a blood sample Generative AI - Image credit: catalin | stock.adobe.com
FDA Grants Fast Track Designation for SNB-101 to Treat Small Cell Lung Cancer

May 13th 2024

red blood cells circulating in the blood vessels | Image Credit: Design Cells - stock.adobe.com
FDA Approves Updated Label for Altuviiio to include Full Data on Pediatric Patients With Hemophilia A

May 13th 2024

biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
FDA Approves sBLA for Adalimumab-adaz as Interchangeable Biosimilar for Humira

May 10th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.